This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEB6J0AJ_M.jpg
In 2021, most Canadian stocks continue to trade significantly below their record highs. These companies have been impacted by lower-than-expected demand, negative profit margins, and overvalued acquisitions.
Yet, some Canadian cannabis stocks have staged somewhat of a comeback in the last few months. Today I’ll analyze two such Canadian cannabis stocks: Tilray (TLRY) and OrganiGram (OGI).
